HAS3 Gene - Hyaluronan Synthase 3

Key enzyme in hyaluronan biosynthesis, implicated in cancer progression and inflammatory diseases

Gene Information Card

Symbol HAS3
Full Name hyaluronan synthase 3
Gene Type protein-coding
Chromosomal Location 16q22.1
NCBI Gene ID 3038 ncbi.nlm.nih.gov/gene/3038
Ensembl ID ENSG00000103044
UniProt ID O00219
OMIM ID 603666
HGNC ID 4826
Aliases HAS3, hyaluronate synthase 3, hyaluronic acid synthase 3

Description

HAS3 (hyaluronan synthase 3) encodes a member of the hyaluronan synthase family. This enzyme synthesizes hyaluronan, a high-molecular-weight glycosaminoglycan component of the extracellular matrix. HAS3 is involved in cell adhesion, migration, proliferation, and differentiation. Overexpression is associated with various cancers and inflammatory conditions.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Colorectal cancer HAS3 overexpression increases hyaluronan production, promoting tumor cell proliferation and metastasis PMID: 23454754
Breast cancer Elevated HAS3 expression correlates with poor prognosis and enhanced invasion via hyaluronan-CD44 signaling PMID: 25695677
Osteoarthritis HAS3-mediated hyaluronan synthesis contributes to cartilage matrix remodeling and inflammation PMID: 21575861
Rheumatoid arthritis Increased HAS3 expression in synovial fibroblasts leads to hyaluronan accumulation and joint inflammation PMID: 18593766

Expression Profile

Tissue Expression
Tissue nTPM level
Skin 12.5 Medium
Lung 8.3 Low
Colon 15.7 Medium
Breast 6.2 Low
Ovary 9.1 Low
Prostate 4.8 Not detected
Cell Line Expression
Cell Line nTPM Notes
MCF7 (breast cancer) 18.4 High expression
HCT116 (colorectal cancer) 22.1 High expression
A549 (lung cancer) 7.6 Low expression
HEK293 (embryonic kidney) 3.2 Not detected
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1003G>A (p.Gly335Ser) missense 0.001% Unknown functional effect
c.1246C>T (p.Arg416Cys) missense 0.002% Reported in COSMIC as likely neutral
c.1450_1451insA frameshift <0.001% Predicted loss of function
Mutation functional classification

Loss of Function (LOF)

Frameshift mutations (e.g., c.1450_1451insA) are predicted to truncate the protein, reducing hyaluronan synthesis.

Gain of Function (GOF)

No confirmed gain-of-function mutations reported; overexpression is primarily transcriptional.

Dominant Negative (DN)

No dominant-negative mutations documented.

Pathways

Hyaluronan biosynthesis (Reactome: R-HSA-2142850)
Extracellular matrix organization (Reactome: R-HSA-1474244)
CD44-mediated signaling (KEGG: hsa04512)

Protein Summary

HAS3 is a 554-amino-acid transmembrane protein localized to the plasma membrane and Golgi apparatus. It catalyzes the addition of glucuronic acid and N-acetylglucosamine to hyaluronan chains. The protein has multiple transmembrane domains and a central cytoplasmic loop essential for catalytic activity. Hyaluronan produced by HAS3 is typically of lower molecular weight compared to HAS1/HAS2, influencing cell signaling and matrix remodeling.

Related Products

Product name Cat.No. Species Gene ID
HAS3 Knockout HEK293 Cell Line EDJ-KQ4843 Human 3038 Details Get a Quote
HAS3 Knockout HCT 116 Cell Line EDJ-KQ26410 Human 3038 Details Get a Quote
HAS3 Knockout A-549 Cell Line EDJ-KQ27626 Human 3038 Details Get a Quote
HAS3 Knockout HeLa Cell Line EDJ-KQ53491 Human 3038 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: